There is a newer version of the record available.

Published February 6, 2018 | Version v1

HTT Overexpression Optimisation in Mammalian Cells

  • 1. SGC, University of Toronto

Description

HTT Overexpression Optimisation in Mammalian Cells

Notes

Funding acknowledgement The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.

Files

Files (614.0 kB)

Name Size Download all
md5:f055c6736522ff38ebd0f306fe619a1f
22.6 kB Download
md5:8581b20834685c9ce204d2fc22df9ed2
591.4 kB Download